Does TAMOXIFEN Cause Hepatic lesion? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Hepatic lesion have been filed in association with TAMOXIFEN (Tamoxifen Citrate). This represents 0.8% of all adverse event reports for TAMOXIFEN.
71
Reports of Hepatic lesion with TAMOXIFEN
0.8%
of all TAMOXIFEN reports
1
Deaths
11
Hospitalizations
How Dangerous Is Hepatic lesion From TAMOXIFEN?
Of the 71 reports, 1 (1.4%) resulted in death, 11 (15.5%) required hospitalization.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAMOXIFEN. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does TAMOXIFEN Cause?
Malignant neoplasm progression (1,499)
Metastases to bone (894)
Fatigue (729)
Nausea (611)
Metastases to liver (595)
Breast cancer (584)
Disease progression (571)
Breast cancer metastatic (515)
Diarrhoea (512)
Arthralgia (497)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which TAMOXIFEN Alternatives Have Lower Hepatic lesion Risk?
TAMOXIFEN vs TAMSULOSIN
TAMOXIFEN vs TAPENTADOL
TAMOXIFEN vs TAPINAROF
TAMOXIFEN vs TARCEVA
TAMOXIFEN vs TARLATAMAB